ProCE Banner Activity

Key Takeaways From IDWeek 2023 on COVID-19 Risk Factors, Clinical Outcomes, and Future Therapeutics

Clinical Thought

The COVID-19 pandemic is still alive and with us. Data from IDWeek 2023 shed light on the current at-risk populations for developing severe illness, COVID-19 outcomes in people with immunocompromise, and future COVID-19 therapeutic options.

Released: November 06, 2023

Share

Faculty

Arthur Kim

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc. and Novavax, Inc.

Gilead Sciences, Inc.

Novavax, Inc.

Disclosure

Primary Author

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD: consultant/advisor/speaker: Kintor Pharmaceuticals.